Press release
View this email in your browser

Press Release

Cato Research announces merger with SMS-oncology

Combination Broadens Company’s Global Solutions Supporting Drug Development

 
DURHAM, NC – October 28, 2019 - Cato Research, LLC (CATO) announced today that it has merged with Specialized Medical Services-oncology BV (SMS-oncology) to bolster its portfolio of global solutions dedicated to supporting life science organizations with advancing drug development.  The combined company will transition to the new name, CATO SMS, in the coming year.

By joining forces, CATO and SMS-oncology expand their presence across Europe and North America, deepen their oncology and regulatory expertise, and broaden their suite of services. Headquartered in Schiphol, the Netherlands, SMS-oncology is one of the few..   Read more >
SMS-oncology is one of the few full-service contract research organizations (CROs) in the world solely dedicated to oncology. With our unique business model of integrating oncology drug development affairs and clinical operations, we cover the whole value chain from trial design to the setup, management, and completion of phase I to IV oncology trials. We specialize in early phase, pediatric and immuno-oncology trials.
Website Website
LinkedIn LinkedIn
Twitter Twitter
Copyright © 2019 SMS-oncology BV, All rights reserved.


Our mailing address is:
info@sms-oncology.com

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp